Skip to main content
Midas Edge

XCel Brands, Inc.

For the period ended Dec 31, 2025. Filed Apr 15, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Apr 15, 2026

XELB$0.43+6.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

​​​​​​​​​​​​​​​​​​
​ · ​ · Xcel Brands, Inc. Stockholders · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Common Stock · ​ · Paid-in · ​ · Accumulated · ​ · Noncontrolling · ​ · ​ · ​
​ · ​ ​ ​ · Shares(1) · ​ ​ ​ · Amount(1) · ​ ​ ​ · Capital(1) · ​ ​ ​ · Deficit · ​ ​ ​ · Interest · ​ ​ ​ · Total
Balance as of January 1, 20241,979,413​$2​$103,879​$(53,849)​$(1,861)​$48,171
​​​​​​​​​​​​​​​​​​
Compensation expense related to stock options and restricted stock—​—​138​—​—​138
​​​​​​​​​​​​​​​​​​
Contra-revenue related to warrants held by licensee​—​​—​​38​​—​—​38
​​​​​​​​​​​​​​​​​​
Shares issued to directors in connection with restricted stock grants​4,000​​—​​—​​—​—​—
​​​​​​​​​​​​​​​​​​
Shares issued to consultant in connection with stock grants​7,800​​—​​98​​—​—​98
​​​​​​​​​​​​​​​​​​
Shares issued to employee in connection with stock grant​1,468​​—​10​​—​​—​​10
​​​​​​​​​​​​​​​​​​
Shares issued to executives for pro rata portion of base salaries, net of withholding taxes​17,502​​—​120​—​—​120
​​​​​​​​​​​​​​​​​​
Shares issued in connection with public offering and private placement transactions, net of transaction costs​357,889​​—​​1,902​—​—​1,902
​​​​​​​​​​​​​​​​​​
Warrants issued in connection with refinancing of term loan debt​—​​—​​481​​—​​—​​481
​​​​​​​​​​​​​​​​​​
Net loss for the year ended December 31, 2024—​—​—​(22,395)​(165)​(22,560)
​​​​​​​​​​​​​​​​​​
Balance as of December 31, 20242,368,072​2​106,666​(76,244)​(2,026)​28,398
​​​​​​​​​​​​​​​​​​
Additional impact related to fractional shares from reverse stock split​(57)​​—​—​—​—​—
​​​​​​​​​​​​​​​​​​
Compensation expense related to stock options and restricted stock—​—​222​—​—​222
​​​​​​​​​​​​​​​​​​
Contra-revenue related to warrants held by licensee​—​—​38​—​—​38
​​​​​​​​​​​​​​​​​​
Shares issued to directors in connection with restricted stock grants​43,584​​—​​—​​—​—​—
​​​​​​​​​​​​​​​​​​
Shares issued to directors and management in connection with other restricted stock grants​17,500​​—​​—​​—​​—​​—
​​​​​​​​​​​​​​​​​​
Shares issued to directors in connection with stock grants​45,000​​—​​42​​—​​—​​42
​​​​​​​​​​​​​​​​​​
Shares issued to employee in connection with stock grant​63,674​​—​46​—​—​46
​​​​​​​​​​​​​​​​​​
Shares issued to executives for pro rata portion of base salaries, net of withholding taxes​121,998​​—​222​—​—​222
​​​​​​​​​​​​​​​​​​
Shares issued in connection with public offering and private placement transactions, net of transaction costs​2,324,860​​3​​1,962​​—​​—​​1,965
​​​​​​​​​​​​​​​​​​
Shares and warrants issued in connection with private investment in public equity transaction, net of transaction costs​896,126​​1​​1,814​​—​​—​​1,815
​​​​​​​​​​​​​​​​​​
Warrants issued and amended in connection with refinancing of term loan debt​—​​—​​648​​—​​—​​648
​​​​​​​​​​​​​​​​​​
Net loss for the year ended December 31, 2025—​—​—​(17,461)​(111)​(17,572)
​​​​​​​​​​​​​​​​​​
Balance as of December 31, 20255,880,757​$6​$111,660​$(93,705)​$(2,137)​$15,824
(1)The values of Common stock and Paid-in capital, as well as the number of shares issued and outstanding, have been retroactively adjusted in order to give effect to the Company’s 1-for-10 reverse stock split. See Note 2 and Note 7.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.